Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Chronic Graft-versus-Host Disease Clinical Trials Near Me

As of November 13, 2026, 77 Chronic Graft-versus-Host Disease clinical trials are recruiting now and 16 are not yet recruiting. In the US, 47 of them have at least 1 open site, across 31 states and Washington, DC. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Chronic Graft-versus-Host Disease pageMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+72 more

All 77 Chronic Graft-versus-Host Disease trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
    Most sites in California, Florida and Michigan
    RecruitingPhase 3Ages 12+Incyte
    37US sites
    23 states
  2. Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
    Most sites in Illinois, Florida and Texas
    RecruitingAges 18+Incyte
    36US sites
    23 states
  3. A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
    Most sites in Michigan, North Carolina and California
    RecruitingPhase 3Ages 18+Incyte
    30US sites
    19 states
  4. A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
    Most sites in California, Ohio and Florida
    RecruitingPhase 2Ages 18+Deciphera Pharmaceuticals
    26US sites
    18 states
  5. A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
    Most sites in Alabama, California and Florida
    RecruitingPhase 2Ages 2+Syndax Pharmaceuticals
    13US sites
    13 states
  6. A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
    Most sites in California, Florida and North Carolina
    RecruitingPhase 2Ages 2-17Incyte
    12US sites
    8 states
  7. A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
    Most sites in New York, New Jersey and Maryland
    RecruitingPhase 2Ages 4+Memorial Sloan Kettering Cancer Center
    9US sites
    4 states
  8. A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
    Most sites in New York and New Jersey
    RecruitingPhase 2Ages 18+Memorial Sloan Kettering Cancer Center
    8US sites
    2 states
  9. A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
    Most sites in California, District of Columbia and Georgia
    RecruitingPhase 2Ages 1-18Sanofi
    7US sites
    7 states
  10. BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
    Most sites in Massachusetts, California and Michigan
    RecruitingPhase 2Ages 18+Dana-Farber Cancer Institute
    6US sites
    4 states
  11. Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
    Most sites in California, Georgia and Massachusetts
    RecruitingAges 36 Months+University of Michigan Rogel Cancer Center
    6US sites
    6 states
  12. Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
    Most sites in Florida, Virginia and Kansas
    RecruitingPhase 2Ages 18+H. Lee Moffitt Cancer Center and Research Institute
    6US sites
    4 states
  13. Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
    Most sites in California, Florida and Massachusetts
    RecruitingPhase 2Ages 18+Fred Hutchinson Cancer Center
    5US sites
    5 states
  14. Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
    Most sites in California, Massachusetts and Minnesota
    RecruitingPhase 1Ages 18+Tr1X
    5US sites
    5 states
  15. Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
    Most sites in Georgia, Illinois and Massachusetts
    RecruitingPhase 2Ages 2+Boston Children's Hospital
    4US sites
    4 states
  16. Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
    Most sites in Florida, Massachusetts and Washington
    RecruitingPhase 2Ages 18+Fred Hutchinson Cancer Center
    3US sites
    3 states
  17. Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
    Most sites in California, Florida and Illinois
    RecruitingPhase 2Ages 12+University of Miami
    3US sites
    3 states
  18. Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
    Most sites in Florida, New York and Ohio
    RecruitingPhase 2Ages 18+Children's Hospital Medical Center, Cincinnati
    3US sites
    3 states
  19. Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
    Most sites in Florida and Massachusetts
    RecruitingAges 18+Massachusetts General Hospital
    2US sites
    2 states
  20. Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Most sites in Florida and Maryland
    RecruitingPhase 1/2Ages 18-120National Cancer Institute (NCI)
    2US sites
    2 states
Get an email when Chronic Graft-versus-Host Disease trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Chronic Graft-versus-Host Disease:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Chronic Graft-versus-Host Disease trials in the US, and what stage they are in

Of the 47 Chronic Graft-versus-Host Disease trials with a US site, 2 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 31 of them. The remaining 14 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 8 of them, and universities, hospitals, foundations and government groups run 39. The sponsors with the most are City of Hope Medical Center (5), Incyte (4) and Fred Hutchinson Cancer Center (3). The most recently listed one first appeared on ClinicalTrials.gov on September 8, 2026.

Chronic Graft-versus-Host Disease trials in the US, state by state

Of the 47 Chronic Graft-versus-Host Disease trials with a US site, 16 accept children under 18. Their open sites are in 25 states and Washington, DC, most often California, New York and Georgia. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
California18817Duarte (11), Los Angeles (6), San Francisco (4), plus 4 more
Massachusetts15615Boston (15)
Florida14413Miami (8), Tampa (6), Orlando (4), plus 3 more
New York13712New York (9), Commack (2), Harrison (2), plus 6 more
Washington11410Seattle (11)
Georgia968Atlanta (9), Augusta (1)
Pennsylvania948Pittsburgh (5), Philadelphia (3), Danville (1), plus 1 more
Maryland858Bethesda (6), Baltimore (2)
Michigan838Detroit (6), Ann Arbor (4), Grand Rapids (2)
Texas838Houston (5), Austin (3), Dallas (2), plus 1 more
Show the other 22 states
Illinois747Chicago (7), Maywood (1)
Ohio717Columbus (6), Cleveland (3), Cincinnati (1)
North Carolina625Charlotte (4), Durham (4), Chapel Hill (2), plus 1 more
Kansas515Kansas City (3), Fairway (1), Westwood (1)
Oregon525Portland (5)
Missouri414St Louis (4)
New Jersey424Basking Ridge (2), Middletown (2), Montvale (2), plus 2 more
Tennessee414Nashville (3), Memphis (1)
Utah424Salt Lake City (4)
Virginia414Richmond (4), Charlottesville (1)
Wisconsin404Milwaukee (3), Madison (2)
Alabama323Birmingham (3)
District of Columbia332Washington D.C. (3)
Arizona212Phoenix (1), Tucson (1)
Colorado212Denver (2), Aurora (1)
Minnesota202Minneapolis (1), Rochester (1)
South Carolina212Charleston (2), Greenville (1)
Indiana101Indianapolis (1)
Kentucky101Lexington (1)
Nebraska101Omaha (1)
South Dakota101Sioux Falls (1)
West Virginia111Morgantown (1)

US hospitals running the most Chronic Graft-versus-Host Disease trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Chronic Graft-versus-Host Disease.

  1. City of Hope Medical CenterDuarte, California7 trials
  2. Dana-Farber Cancer InstituteBoston, Massachusetts6 trials
  3. Moffitt Cancer CenterTampa, Florida6 trials
  4. Fred Hutchinson Cancer Research CenterSeattle, Washington5 trials
  5. National Institutes of Health Clinical CenterBethesda, Maryland5 trials
  6. Levine Cancer InstituteCharlotte, North Carolina4 trials
  7. Massachusetts General HospitalBoston, Massachusetts4 trials
  8. Memorial Sloan Kettering Cancer CenterNew York, New York4 trials
  9. University of MiamiMiami, Florida4 trials
  10. City of HopeDuarte, California3 trials

Help getting to a Chronic Graft-versus-Host Disease trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Ronald McDonald House
Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding a Chronic Graft-versus-Host Disease trial near you

Are there Chronic Graft-versus-Host Disease clinical trials near me?

As of November 13, 2026, 77 Chronic Graft-versus-Host Disease clinical trials are recruiting now and 16 are not yet recruiting. In the US, 47 of them have at least 1 open site, across 31 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Chronic Graft-versus-Host Disease clinical trial sites?

Recruiting Chronic Graft-versus-Host Disease trials list open sites in 31 states and Washington, DC. California, Massachusetts and Florida have the most, and the table on this page lists every state.

Are there Chronic Graft-versus-Host Disease trials for children near me?

Of the 47 Chronic Graft-versus-Host Disease trials with a US site, 16 accept children under 18. Their open sites are in 25 states and Washington, DC, most often California, New York and Georgia. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to a Chronic Graft-versus-Host Disease clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.

What if there is no Chronic Graft-versus-Host Disease trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Chronic Graft-versus-Host Disease trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for Chronic Graft-versus-Host Disease: Imbruvica (ibrutinib), Jakafi (ruxolitinib), Niktimvo (axatilimab), Rezurock (belumosudil).

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.